At a glance
ClinicalIndex Comparison RecordN/ACompleted· 220 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Chronisch Obstruktive Lungenerkrankung Und Pulmonale Hypertonie: Prävalenz Und Lebensqualität
In Brief
An observational study for Hypertension, Pulmonary and Pulmonary Disease, Chronic Obstructive. Completed, enrolled 220 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the prevalence of pulmonary hypertension (PH) among patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and to assess the quality of life in those patients with concomitant PH compared to COPD patients without PH and those only suffering from pulmonary arterial hypertension (PAH) respectively.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
CollaboratorsActelion Pharmaceuticals Deutschland GmbH
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedAug 2011
Primary CompletionJan 2015
TodayJul 2026
First PostedAug 25, 2011
Enrollment StartAug 1, 2011
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 14.9 years ago